Roman Butler Fullerton & CO Johnson & Johnson Transaction History

Roman Butler Fullerton & CO

$295 Million
Q2 2024

A detailed history of Roman Butler Fullerton & CO transactions in Johnson & Johnson stock. As of the latest transaction made, Roman Butler Fullerton & CO holds 12,625 shares of JNJ stock, worth $2.08 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

12,625

Previous 12,763 1.08%

Holding current value

$2.08 Million

Previous $2.02 Million 8.57%

% of portfolio

0.63%

Previous 0.73%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	SELL	$144.38 - $157.78 $19,924 - $21,773	-138 Reduced 1.08%	12,625 $1.85 Million
Q1 2024 Apr 29, 2024	SELL	$155.22 - $162.74 $10,399 - $10,903	-67 Reduced 0.52%	12,763 $2.02 Million
Q4 2023 Jan 31, 2024	SELL	$145.6 - $158.88 $61,006 - $66,570	-419 Reduced 3.16%	12,830 $2.01 Million
Q3 2023 Oct 18, 2023	SELL	$155.75 - $174.48 $96,720 - $108,352	-621 Reduced 4.48%	13,249 $2.06 Million
Q2 2023 Jul 25, 2023	SELL	$154.35 - $166.11 $64,981 - $69,932	-421 Reduced 2.95%	13,870 $2.3 Million
Q1 2023 Apr 27, 2023	BUY	$151.05 - $180.26 $256,180 - $305,720	1,696 Added 13.47%	14,291 $2.22 Million
Q4 2022 Jan 23, 2023	BUY	$160.2 - $179.79 $159,078 - $178,531	993 Added 8.56%	12,595 $0
Q3 2022 Oct 17, 2022	BUY	$161.33 - $179.52 $40,493 - $45,059	251 Added 2.21%	11,602 $1.89 Million
Q2 2022 Jul 26, 2022	BUY	$168.19 - $186.01 $20,855 - $23,065	124 Added 1.1%	11,351 $2.02 Million
Q1 2022 May 05, 2022	SELL	$158.14 - $179.59 $92,828 - $105,419	-587 Reduced 4.97%	11,227 $1.99 Million
Q4 2021 Jan 24, 2022	BUY	$155.93 - $173.01 $80,303 - $89,100	515 Added 4.56%	11,814 $2.02 Million
Q3 2021 Nov 10, 2021	SELL	$161.5 - $179.47 $75,905 - $84,350	-470 Reduced 3.99%	11,299 $1.81 Million
Q2 2021 Jul 29, 2021	SELL	$159.48 - $171.07 $3,986 - $4,276	-25 Reduced 0.21%	11,769 $1.94 Million
Q1 2021 Apr 22, 2021	BUY	$153.07 - $170.48 $10,255 - $11,422	67 Added 0.57%	11,794 $1.89 Million
Q4 2020 Feb 01, 2021	BUY	$137.11 - $157.38 $3,976 - $4,564	29 Added 0.25%	11,727 $1.85 Million
Q3 2020 Oct 15, 2020	SELL	$140.38 - $153.83 $6,176 - $6,768	-44 Reduced 0.37%	11,698 $1.74 Million
Q2 2020 Jul 28, 2020	BUY	$128.81 - $155.51 $100,858 - $121,764	783 Added 7.14%	11,742 $1.65 Million
Q1 2020 Apr 13, 2020	SELL	$111.14 - $153.99 $42,122 - $58,362	-379 Reduced 3.34%	10,959 $1.44 Million
Q4 2019 Jan 27, 2020	SELL	$127.5 - $146.44 $54,952 - $63,115	-431 Reduced 3.66%	11,338 $1.65 Million
Q3 2019 Oct 15, 2019	SELL	$126.95 - $142.14 $126,061 - $141,145	-993 Reduced 7.78%	11,769 $1.52 Million
Q2 2019 Jul 22, 2019	BUY	$131.15 - $144.24 $22,164 - $24,376	169 Added 1.34%	12,762 $1.78 Million
Q1 2019 Apr 24, 2019	BUY	$125.72 - $139.79 $23,509 - $26,140	187 Added 1.51%	12,593 $1.76 Million
Q4 2018 Feb 04, 2019	BUY	$122.84 - $147.84 $1.52 Million - $1.83 Million	12,406 New	12,406 $1.61 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roman Butler Fullerton & CO, based on Form 13F filings with the SEC.

News

Stay updated on Roman Butler Fullerton & CO with notifications on news.

Account

Roman Butler Fullerton & CO Johnson & Johnson Transaction History